Discussion of Schuemie et al: "A plea to stop using the case-control design in retrospective database studies"

Affiliations

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital and Department of Epidemiology and Biostatistics, McGill University, Montréal, Québec, Canada.

Comment

Sebastian Schneeweiss et al. Stat Med. 2019.

. 2019 Sep 30;38(22):4209-4212.

doi: 10.1002/sim.8320.

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital and Department of Epidemiology and Biostatistics, McGill University, Montréal, Québec, Canada.

No abstract available

Comment on

A plea to stop using the case-control design in retrospective database studies.
Schuemie MJ, Ryan PB, Man KKC, Wong ICK, Suchard MA, Hripcsak G. Schuemie MJ, et al. Stat Med. 2019 Sep 30;38(22):4199-4208. doi: 10.1002/sim.8215. Epub 2019 Aug 22. Stat Med. 2019. PMID: 31436848 Free PMC article.

1. Miettinen OS. Estimation of relative risk from individually matched series. Biometrics 1970;26(1):75-86.
1. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976;103(2):226-235.
1. Wacholder S. Practical considerations in choosing between the case-cohort and nested case-control designs. Epidemiology. 1991;2(2):155-158.
1. Ernst P, Habbick B, Suissa S, et al. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis. 1993;148(1):75-79.
1. Moore N, Duret S, Grolleau A, et al. Previous drug exposure in patients hospitalised for acute liver injury: a case-population study in the French National Healthcare Data System. Drug Saf. 2019;42(4):559-572.